Myelodysplastic syndromes

Anita Kinney, Margaret T. Harle

Research output: Contribution to journalArticle

Abstract

A cure for MDS has yet to be found. The aim of therapy is to attempt to restore normal hematopoiesis and prevent evolution to acute leukemia. The major trend is supportive care. Blood counts and bone marrow aspirations are taken to evaluate the disease, and transfusions of blood products and antibiotics are given when necessary. A new encouraging modality of therapy is the use of hematopoietic growth factors to reverse cytopenias. As there is no curative treatment for MDS, the patient is likely to be offered investigational drugs either singly or in combination. Future trends in the treatment of MDS will be combinations of agents including biological agents with retinoic acid or vitamin D, low-dose Ara-C, the interferons, and colony-stimulating factors.

Original languageEnglish (US)
Pages (from-to)9-16
Number of pages8
JournalSeminars in Oncology Nursing
Volume6
Issue number1
DOIs
StatePublished - Jan 1 1990
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology(nursing)

Fingerprint Dive into the research topics of 'Myelodysplastic syndromes'. Together they form a unique fingerprint.

Cite this